Thermo Fisher Scientific | TMO - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Abbott USD 299M 231M 2026-06
Agilent USD 29M 4M 2026-06
Becton, Dickinson and Co. USD 132M 17M 2026-06
Bio Techne USD 3.6M 1.19M 2026-06
Bio-Rad Laboratories USD 12.1M 200K 2026-06
Boston Scientific USD 96M 6M 2026-06
Bruker USD 17.8M 9.7M 2026-06
Charles River Laboratories USD 30.34M 3.6M 2026-06
Danaher USD 135M 28M 2026-09
Dentsply International USD 22M 2M 2026-06
Edwards Lifesciences USD 30M 5.9M 2026-06
General Electric Aerospace USD 231M 265M 2026-09
Henry Schein USD 43M 4M 2026-06
Illumina USD 24M 2M 2026-03
Intuitive Surgical USD 20.88B 765.6M 2026-06
IQVIA Holdings USD 197M 5M 2026-06
Laboratory Of America USD 61.1M 6M 2026-06
Medtronic USD 186M 10M 2026-06
Mettler Toledo International USD 17.25M 239K 2026-06
Myriad Genetics USD 4.4M 600K 2025-12
Olympus JPY 2.82B 2.31B 2026-06
OraSure Technologies 1.67M 1.13M 2025-12
Quest Diagnostics USD 69M 2M 2025-09
Repligen USD 5.66M 85K 2026-06
Revvity USD 22.99M 1.73M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Thermo Fisher Scientific USD 354M 11M 2026-03
Veracyte USD 2K 1000 2023-12
Waters USD 55M 13M 2026-06
Zimmer Biomet Holdings USD 22.8B 22.73B 2026-06